Quarterly ResultMay 7, 2026, 07:02 AM
Rockwell Medical Q1 Net Sales Down 8.3% to $17.3M; Net Loss $1.6M
AI Summary
Rockwell Medical reported a decrease in net sales and an increase in net loss for the first quarter of 2026 compared to the same period in 2025. Net sales fell by 8.3% to $17.3 million, while net loss grew to $1.6 million. Despite these financial declines, the company improved its net cash used in operating activities and maintains $23.9 million in cash, cash equivalents, and available-for-sale investments, with management believing it has sufficient funds for the next twelve months. However, a significant customer, DaVita, plans to transition to another supplier, although their agreement has been extended through December 2026.
Key Highlights
- Net sales decreased 8.3% to $17.3 million for Q1 2026 from $18.9 million in Q1 2025.
- Net loss increased to $1.6 million for Q1 2026, up from $1.5 million in Q1 2025.
- Basic and diluted net loss per share remained at $(0.04) for both periods.
- Cash and cash equivalents were $9.6 million as of March 31, 2026.
- Working capital stood at $27.1 million as of March 31, 2026.
- Net cash used in operating activities significantly improved to $0.2 million in Q1 2026 from $3.5 million in Q1 2025.
- The company has $13.1 million remaining on its at-the-market (ATM) facility.
- DaVita, a major customer, intends to transition to another supplier, though the agreement was extended through December 2026.
Price Impact
More from RMTI